Literature DB >> 3164708

Paracrine influence of human breast stromal fibroblasts on breast epithelial cells: secretion of a polypeptide which stimulates reductive 17 beta-oestradiol dehydrogenase activity.

E F Adams1, C J Newton, G H Tait, H Braunsberg, M J Reed, V H James.   

Abstract

We have previously shown that a stroma-associated paracrine influence may occur in the human breast. In particular, human breast fibroblasts secrete a factor which stimulates reductive 17 beta-oestradiol dehydrogenase (HSD) activity, thereby regulating tissue concentrations of 17 beta-oestradiol. We report here the results of experiments designed to establish the nature of the enzyme activity stimulating factor. In vitro cell culture techniques were used, in which human breast fibroblast-conditioned medium was used to grow the human breast cancer cell line, MCF-7, for 6 days, after which the reductive HSD activity of the monolayers was assessed. The fibroblastic reductive HSD stimulating factor was found to be a trypsin-sensitive polypeptide. The polypeptide eluted from a Sephadex G-75 column as a peak corresponding to a molecular weight of about 50 kDa. The polypeptide exerts its effects by altering the Vmax of 2 of the cytosolic forms of HSD within MCF-7 cells. This is achieved by a protein-synthesis-dependent but calmodulin-independent mechanism. These results provide further evidence of a paracrine effect by stromal tissue within the human breast and have important implications with respect to the aetiology and treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164708     DOI: 10.1002/ijc.2910420122

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Cellular interactions in metastasis.

Authors:  F R Miller; G H Heppner
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

2.  Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell death.

Authors:  Mireia Berdiel-Acer; Monika E Bohem; Adriana López-Doriga; August Vidal; Ramon Salazar; Maria Martínez-Iniesta; Cristina Santos; Xavier Sanjuan; Alberto Villanueva; David G Molleví
Journal:  Neoplasia       Date:  2011-10       Impact factor: 5.715

3.  Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.

Authors:  S Li; C Lévesque; C S Geng; X Yan; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

4.  Effects of lymphocytes and fibroblasts on the growth of human mammary carcinoma cells studied in short-term primary cultures.

Authors:  H M Ogmundsdóttir; I Pétursdóttir; I Gudmundsdóttir; L Amundadóttir; L Rønnov-Jessen; O W Petersen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-12       Impact factor: 2.416

5.  Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+.

Authors:  M W Sawicki; M Erman; T Puranen; P Vihko; D Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

6.  The inhibitory effect caused by suramin on the paracrine growth of human cancer cells and fibroblasts.

Authors:  H Mukaida; N Hirabayashi; T Hirai; Y Yamashita; T Iwata; S Saeki; T Toge
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

7.  Dehydroepiandrosterone and estrone 17-ketosteroid reductases in MCF-7 human breast cancer cells.

Authors:  J H MacIndoe; M Hinkhouse; G Woods
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

8.  Fibroblast stimulation of breast cancer cell growth in a serum-free system.

Authors:  M C Ryan; D J Orr; K Horgan
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

9.  Stromal influences on breast cancer cell growth.

Authors:  C E van Roozendaal; B van Ooijen; J G Klijn; C Claassen; A M Eggermont; S C Henzen-Logmans; J A Foekens
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.